These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 17473184

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells.
    Corona G, Giannini F, Fabris M, Toffoli G, Boiocchi M.
    Int J Cancer; 1998 Jan 05; 75(1):125-33. PubMed ID: 9426700
    [Abstract] [Full Text] [Related]

  • 3. Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate.
    Pinard MF, Jolivet J, Ratnam M, Kathmann I, Molthoff C, Westerhof R, Schornagel JH, Jansen G.
    Cancer Chemother Pharmacol; 1996 Jan 05; 38(3):281-8. PubMed ID: 8646804
    [Abstract] [Full Text] [Related]

  • 4. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
    Westerhof GR, Rijnboutt S, Schornagel JH, Pinedo HM, Peters GJ, Jansen G.
    Cancer Res; 1995 Sep 01; 55(17):3795-802. PubMed ID: 7641196
    [Abstract] [Full Text] [Related]

  • 5. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
    Jansen G, Mauritz RM, Assaraf YG, Sprecher H, Drori S, Kathmann I, Westerhof GR, Priest DG, Bunni M, Pinedo HM, Schornagel JH, Peters GJ.
    Adv Enzyme Regul; 1997 Sep 01; 37():59-76. PubMed ID: 9381986
    [Abstract] [Full Text] [Related]

  • 6. Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines.
    Miotti S, Bagnoli M, Ottone F, Tomassetti A, Colnaghi MI, Canevari S.
    J Cell Biochem; 1997 Jun 15; 65(4):479-91. PubMed ID: 9178098
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of methotrexate resistance in osteosarcoma.
    Guo W, Healey JH, Meyers PA, Ladanyi M, Huvos AG, Bertino JR, Gorlick R.
    Clin Cancer Res; 1999 Mar 15; 5(3):621-7. PubMed ID: 10100715
    [Abstract] [Full Text] [Related]

  • 8. The role of alpha-folate receptor-mediated transport in the antitumor activity of antifolate drugs.
    Theti DS, Jackman AL.
    Clin Cancer Res; 2004 Feb 01; 10(3):1080-9. PubMed ID: 14871988
    [Abstract] [Full Text] [Related]

  • 9. A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance.
    Jansen G, Mauritz R, Drori S, Sprecher H, Kathmann I, Bunni M, Priest DG, Noordhuis P, Schornagel JH, Pinedo HM, Peters GJ, Assaraf YG.
    J Biol Chem; 1998 Nov 13; 273(46):30189-98. PubMed ID: 9804775
    [Abstract] [Full Text] [Related]

  • 10. Antifolate resistance in a HeLa cell line associated with impaired transport independent of the reduced folate carrier.
    Zhao R, Chattopadhyay S, Hanscom M, Goldman ID.
    Clin Cancer Res; 2004 Dec 15; 10(24):8735-42. PubMed ID: 15623659
    [Abstract] [Full Text] [Related]

  • 11. Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line.
    Dixon KH, Trepel JB, Eng SC, Cowan KH.
    Cancer Commun; 1991 Dec 15; 3(12):357-65. PubMed ID: 16296001
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier.
    Wang Y, Zhao R, Goldman ID.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6256-64. PubMed ID: 15448015
    [Abstract] [Full Text] [Related]

  • 13. Placental folate transport and binding are not impaired in pregnancies complicated by fetal growth restriction.
    Bisseling TM, Steegers EA, van den Heuvel JJ, Siero HL, van de Water FM, Walker AJ, Steegers-Theunissen RP, Smits P, Russel FG.
    Placenta; 2004 Jul 15; 25(6):588-93. PubMed ID: 15135243
    [Abstract] [Full Text] [Related]

  • 14. Reduced folate carrier protein expression in osteosarcoma: implications for the prediction of tumor chemosensitivity.
    Ifergan I, Meller I, Issakov J, Assaraf YG.
    Cancer; 2003 Nov 01; 98(9):1958-66. PubMed ID: 14584080
    [Abstract] [Full Text] [Related]

  • 15. Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines.
    Moscow JA, Connolly T, Myers TG, Cheng CC, Paull K, Cowan KH.
    Int J Cancer; 1997 Jul 03; 72(1):184-90. PubMed ID: 9212241
    [Abstract] [Full Text] [Related]

  • 16. Lack of impact of the loss of constitutive folate receptor alpha expression, achieved by RNA Interference, on the activity of the new generation antifolate pemetrexed in HeLa cells.
    Chattopadhyay S, Wang Y, Zhao R, Goldman ID.
    Clin Cancer Res; 2004 Dec 01; 10(23):7986-93. PubMed ID: 15585634
    [Abstract] [Full Text] [Related]

  • 17. Characterization of folate transport mediated by a low pH route in mouse L1210 leukemia cells with defective reduced folate carrier function.
    Sierra EE, Goldman ID.
    Biochem Pharmacol; 1998 May 01; 55(9):1505-12. PubMed ID: 10076544
    [Abstract] [Full Text] [Related]

  • 18. Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.
    Patiño-García A, Zalacaín M, Marrodán L, San-Julián M, Sierrasesúmaga L.
    J Pediatr; 2009 May 01; 154(5):688-93. PubMed ID: 19159907
    [Abstract] [Full Text] [Related]

  • 19. Resistance to methotrexate in SKOV-3 cell lines after chronic exposure to carbamazepine is associated with a decreased expression of folate receptor.
    Toffoli G, Corona G, Tolusso B, Sartor F, Sorio R, Mini E, Boiocchi M.
    Int J Cancer; 2000 Mar 01; 85(5):683-90. PubMed ID: 10699949
    [Abstract] [Full Text] [Related]

  • 20. Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells.
    Serra M, Reverter-Branchat G, Maurici D, Benini S, Shen JN, Chano T, Hattinger CM, Manara MC, Pasello M, Scotlandi K, Picci P.
    Ann Oncol; 2004 Jan 01; 15(1):151-60. PubMed ID: 14679136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.